Furthermore, a recent meta-analysis involving 46 clinical trials encompassing nearly 12,300 patients utilizing the urine PCA3 test in the diagnosis of prostate cancer was able to reproduce these findings [17]. The gene discussed is PCA3; the disease is Familial prostate cancer.